CYP4F12 is a potential biomarker and inhibits cell migration of head and neck squamous cell carcinoma via EMT pathway

Abstract Head and neck squamous cell carcinoma (HNSC) is the most common malignant tumor of head and neck. Due to the insidious nature of HNSC and the lack of effective early diagnostic indicators, the development of novel biomarkers to improve patient prognosis is particularly urgent. In this study...

Full description

Bibliographic Details
Main Authors: Wenming Jia, Shuai Chen, Ran Wei, Xiaoqi Yang, Minfa Zhang, Ye Qian, Heng Liu, Dapeng Lei
Format: Article
Language:English
Published: Nature Portfolio 2023-07-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-023-37950-z
_version_ 1797784649562324992
author Wenming Jia
Shuai Chen
Ran Wei
Xiaoqi Yang
Minfa Zhang
Ye Qian
Heng Liu
Dapeng Lei
author_facet Wenming Jia
Shuai Chen
Ran Wei
Xiaoqi Yang
Minfa Zhang
Ye Qian
Heng Liu
Dapeng Lei
author_sort Wenming Jia
collection DOAJ
description Abstract Head and neck squamous cell carcinoma (HNSC) is the most common malignant tumor of head and neck. Due to the insidious nature of HNSC and the lack of effective early diagnostic indicators, the development of novel biomarkers to improve patient prognosis is particularly urgent. In this study, we explored and validated the correlation between cytochrome P450 family 4 subfamily F member 12 (CYP4F12) expression levels and HNSC progression using data from The Cancer Genome Atlas (TCGA), Gene Expression Omnibus (GEO) datasets and collected patient samples. We analyzed the association of CYP4F12 expression with clinicopathological features, immune correlation and prognosis. Finally, we analyzed the correlation between CYP4F12 and pathways, and verified by experiments. The results showed that CYP4F12 was low expressed in tumor tissues, participated in a variety of phenotypic changes of HNSC and affected immune cell infiltration. Pathway analysis indicated that CYP4F12 may play a key role in tumor cell migration and apoptosis. Experimental results showed that over-expression of CYP4F12 inhibited cell migration and enhanced the adhesion between cells and matrix by inhibiting epithelial-mesenchymal transition (EMT) pathway in HNSC cells. In conclusion, our study provided insights into the role of CYP4F12 in HNSC and revealed that CYP4F12 may be a potential therapeutic target for HNSC.
first_indexed 2024-03-13T00:42:54Z
format Article
id doaj.art-c2f6a7e190f04009bc42ad2928db0da0
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-03-13T00:42:54Z
publishDate 2023-07-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-c2f6a7e190f04009bc42ad2928db0da02023-07-09T11:13:15ZengNature PortfolioScientific Reports2045-23222023-07-0113111610.1038/s41598-023-37950-zCYP4F12 is a potential biomarker and inhibits cell migration of head and neck squamous cell carcinoma via EMT pathwayWenming Jia0Shuai Chen1Ran Wei2Xiaoqi Yang3Minfa Zhang4Ye Qian5Heng Liu6Dapeng Lei7Department of Otorhinolaryngology, Qilu Hospital of Shandong University, National Health Commission (NHC) Key Laboratory of Otorhinolaryngology (Shandong University)Department of Otorhinolaryngology, Qilu Hospital of Shandong University, National Health Commission (NHC) Key Laboratory of Otorhinolaryngology (Shandong University)Department of Otorhinolaryngology, Qilu Hospital of Shandong University, National Health Commission (NHC) Key Laboratory of Otorhinolaryngology (Shandong University)Department of Otorhinolaryngology, Qilu Hospital of Shandong University, National Health Commission (NHC) Key Laboratory of Otorhinolaryngology (Shandong University)Department of Otolaryngology/Head and Neck Surgery, Institute of Otolaryngology, Affiliated Hospital of Binzhou Medical UniversityDepartment of Otorhinolaryngology, Qilu Hospital of Shandong University, National Health Commission (NHC) Key Laboratory of Otorhinolaryngology (Shandong University)Department of Otorhinolaryngology, Qilu Hospital of Shandong University, National Health Commission (NHC) Key Laboratory of Otorhinolaryngology (Shandong University)Department of Otorhinolaryngology, Qilu Hospital of Shandong University, National Health Commission (NHC) Key Laboratory of Otorhinolaryngology (Shandong University)Abstract Head and neck squamous cell carcinoma (HNSC) is the most common malignant tumor of head and neck. Due to the insidious nature of HNSC and the lack of effective early diagnostic indicators, the development of novel biomarkers to improve patient prognosis is particularly urgent. In this study, we explored and validated the correlation between cytochrome P450 family 4 subfamily F member 12 (CYP4F12) expression levels and HNSC progression using data from The Cancer Genome Atlas (TCGA), Gene Expression Omnibus (GEO) datasets and collected patient samples. We analyzed the association of CYP4F12 expression with clinicopathological features, immune correlation and prognosis. Finally, we analyzed the correlation between CYP4F12 and pathways, and verified by experiments. The results showed that CYP4F12 was low expressed in tumor tissues, participated in a variety of phenotypic changes of HNSC and affected immune cell infiltration. Pathway analysis indicated that CYP4F12 may play a key role in tumor cell migration and apoptosis. Experimental results showed that over-expression of CYP4F12 inhibited cell migration and enhanced the adhesion between cells and matrix by inhibiting epithelial-mesenchymal transition (EMT) pathway in HNSC cells. In conclusion, our study provided insights into the role of CYP4F12 in HNSC and revealed that CYP4F12 may be a potential therapeutic target for HNSC.https://doi.org/10.1038/s41598-023-37950-z
spellingShingle Wenming Jia
Shuai Chen
Ran Wei
Xiaoqi Yang
Minfa Zhang
Ye Qian
Heng Liu
Dapeng Lei
CYP4F12 is a potential biomarker and inhibits cell migration of head and neck squamous cell carcinoma via EMT pathway
Scientific Reports
title CYP4F12 is a potential biomarker and inhibits cell migration of head and neck squamous cell carcinoma via EMT pathway
title_full CYP4F12 is a potential biomarker and inhibits cell migration of head and neck squamous cell carcinoma via EMT pathway
title_fullStr CYP4F12 is a potential biomarker and inhibits cell migration of head and neck squamous cell carcinoma via EMT pathway
title_full_unstemmed CYP4F12 is a potential biomarker and inhibits cell migration of head and neck squamous cell carcinoma via EMT pathway
title_short CYP4F12 is a potential biomarker and inhibits cell migration of head and neck squamous cell carcinoma via EMT pathway
title_sort cyp4f12 is a potential biomarker and inhibits cell migration of head and neck squamous cell carcinoma via emt pathway
url https://doi.org/10.1038/s41598-023-37950-z
work_keys_str_mv AT wenmingjia cyp4f12isapotentialbiomarkerandinhibitscellmigrationofheadandnecksquamouscellcarcinomaviaemtpathway
AT shuaichen cyp4f12isapotentialbiomarkerandinhibitscellmigrationofheadandnecksquamouscellcarcinomaviaemtpathway
AT ranwei cyp4f12isapotentialbiomarkerandinhibitscellmigrationofheadandnecksquamouscellcarcinomaviaemtpathway
AT xiaoqiyang cyp4f12isapotentialbiomarkerandinhibitscellmigrationofheadandnecksquamouscellcarcinomaviaemtpathway
AT minfazhang cyp4f12isapotentialbiomarkerandinhibitscellmigrationofheadandnecksquamouscellcarcinomaviaemtpathway
AT yeqian cyp4f12isapotentialbiomarkerandinhibitscellmigrationofheadandnecksquamouscellcarcinomaviaemtpathway
AT hengliu cyp4f12isapotentialbiomarkerandinhibitscellmigrationofheadandnecksquamouscellcarcinomaviaemtpathway
AT dapenglei cyp4f12isapotentialbiomarkerandinhibitscellmigrationofheadandnecksquamouscellcarcinomaviaemtpathway